Task: Answer the MCQ question.
Question: Which drug exhibits a -28.309% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a Clc1ccc(CSc2nnc(-c3sccc3-n3cccc3)o2)cc1
b O=C(COc1ccccc1)OCC(=O)N1CCCc2ccccc21
c Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2
Answer: c. Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2
Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2
N-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-1,3,4,5-tetrahydro-2-benzazepine-2-carbothioamide